S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Modern Day Options Trading For Beginners! (Ad)pixel
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Want Diversified Exposure in the Regional Banks? Try These ETFs
OTCMKTS:CHSYF

China Medical System - CHSYF Stock Forecast, Price & News

$1.54
0.00 (0.00%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.54
$1.54
50-Day Range
$1.38
$1.54
52-Week Range
$1.54
$1.54
Volume
N/A
Average Volume
2,475 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CHSYF stock logo

About China Medical System (OTCMKTS:CHSYF) Stock

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.

Receive CHSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Medical System and its competitors with MarketBeat's FREE daily newsletter.

CHSYF Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
See More Headlines
Receive CHSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Medical System and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Pharmaceuticals - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CHSYF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
5,292
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Kong Lam (Age 58)
    Founder, Chairman, CEO & Pres
    Comp: $659.55k
  • Ms. Yanling Chen (Age 53)
    CFO, VP & Exec. Director
    Comp: $463.14k
  • Mr. Hongbing Chen (Age 56)
    COO, VP, Director of Sales & Marketing and Exec. Director
    Comp: $603.91k
  • Dr. Wai Ming Wong (Age 62)
    Chief Technical Officer
  • Ms. Sanyan Wu (Age 40)
    Director of Legal Department & Company Sec.













CHSYF Stock - Frequently Asked Questions

How have CHSYF shares performed in 2023?

China Medical System's stock was trading at $1.3810 on January 1st, 2023. Since then, CHSYF stock has increased by 11.5% and is now trading at $1.54.
View the best growth stocks for 2023 here
.

Are investors shorting China Medical System?

China Medical System saw a drop in short interest in February. As of February 15th, there was short interest totaling 1,664,200 shares, a drop of 6.7% from the January 31st total of 1,784,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.
View China Medical System's Short Interest
.

What is China Medical System's stock symbol?

China Medical System trades on the OTCMKTS under the ticker symbol "CHSYF."

How do I buy shares of China Medical System?

Shares of CHSYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Medical System's stock price today?

One share of CHSYF stock can currently be purchased for approximately $1.54.

How many employees does China Medical System have?

The company employs 5,292 workers across the globe.

This page (OTCMKTS:CHSYF) was last updated on 3/28/2023 by MarketBeat.com Staff